Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3786
Peer-review started: March 26, 2020
First decision: April 26, 2020
Revised: April 28, 2020
Accepted: July 30, 2020
Article in press: July 30, 2020
Published online: September 6, 2020
Processing time: 161 Days and 9 Hours
Transendoscopic enteral tubing (TET) has been used in China as a novel delivery route for fecal microbiota transplantation (FMT) into the whole colon with a high degree of patient satisfaction among adults.
To explore the recognition and attitudes of FMT through TET in patients with inflammatory bowel disease (IBD).
An anonymous questionnaire, evaluating their awareness and attitudes toward FMT and TET was distributed among IBD patients in two provinces of Eastern and Southwestern China. Question formats included single-choice questions, multiple-choice questions and sorting questions. Patients who had not undergone FMT were mainly investigated for their cognition and acceptance of FMT and TET. Patients who had experience of FMT, the way they underwent FMT and acceptance of TET were the main interest. Then all the patients were asked whether they would recommend FMT and TET. This study also analyzed the preference of FMT delivery in IBD patients and the patient-related factors associated with it.
A total of 620 eligible questionnaires were included in the analysis. The survey showed that 44.6% (228/511) of patients did not know that FMT is a therapeutic option in IBD, and 80.6% (412/511) of them did not know the concept of TET. More than half (63.2%, 323/511) of the participants stated that they would agree to undergo FMT through TET. Of the patients who underwent FMT via TET [62.4% (68/109)], the majority [95.6% (65/68)] of them were satisfied with TET. Patients who had undergone FMT and TET were more likely to recommend FMT than patients who had not (94.5% vs 86.3%, P = 0.018 and 98.5% vs 87.8%, P = 0.017). Patients’ choice for the delivery way of FMT would be affected by the type of disease and whether the patient had the experience of FMT. When compared to patients without experience of FMT, Crohn’s disease and ulcerative colitis patients who had experience of FMT preferred mid-gut TET (P < 0.001) and colonic TET (P < 0.001), respectively.
Patients’ experience of FMT through TET lead them to maintain a positive attitude towards FMT. The present findings highlighted the significance of patient education on FMT and TET.
Core tip: Fecal microbiota transplantation (FMT) has shown its therapeutic potential in inflammatory bowel disease. Transendoscopic enteral tubing (TET) has been used in China as a novel delivery route for FMT. Perception and attitude towards FMT and TET by physicians and patients play an important role in determining its acceptability. We investigated Chinese inflammatory bowel disease patients’ attitude towards FMT and TET and also examined their preference of FMT delivery. This is the first large-scale study of inflammatory bowel disease patients’ perceptions and attitude towards FMT and TET.